Neurocrine Biosciences Inc. financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 31/07/2026 | Mar 2026Filed 05/05/2026 | Sep 2025Filed 28/10/2025 | Jun 2025Filed 31/07/2026 | Mar 2025Filed 05/05/2026 | Sep 2024Filed 28/10/2025 | Jun 2024Filed 30/07/2025 | Mar 2024Filed 05/05/2025 |
|---|---|---|---|---|---|---|---|---|
| $959 | $815 | $795 | $688 | $573 | $622 | $590 | $515 | |
| $144 | $198 | $210 | $108 | $7.9 | $130 | $65 | $43 | |
| $1.39 | $1.91 | $2.04 | $1.06 | $0.08 | $1.24 | $0.63 | $0.42 | |
| 104 | 103 | 103 | 101 | 103 | 104 | 104 | 104 |
Trend